Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients.
Chueh
S C
SC
Department of Urology, College of Medicine, National Taiwan University, Taipei, People's Republic of China. scchueh@ha.mc.ntu.edu.tw
Huang
C Y
CY
Lai
M K
MK
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001663:Bilirubin